Gabapentin and tinnitus relief.
Shulman
Abraham
A
D000588:Amines / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D011963:Receptors, GABA-A / Q000187:drug effects; D015983:Selection Bias; D014012:Tinnitus / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin